Home » Guidelines & Policy » Atrial fibrillation: diagnosis and management - NICE guideline

Atrial fibrillation: diagnosis and management - NICE guideline

This guideline covers diagnosing and managing atrial fibrillation in adults. It includes guidance on providing the best care and treatment for people with atrial fibrillation, including assessing and managing risks of stroke and bleeding.

The recommendations in this guideline were developed before the COVID-19 pandemic.

 See the MHRA advice on warfarin and other anticoagulants – monitoring of patients during the COVID-19 pandemic, which includes reports of supratherapeutic anticoagulation with warfarin.

Recommendations

This guideline includes new and updated recommendations on:

It also includes recommendations on:

Who is it for?

  • Healthcare professionals
  • Commissioners and providers
  • People with atrial fibrillation, their families and carers